Nov 44 min read
How Patient Voices Are Shaping the Future of MG Care
We are sharing this on behalf of a partner, Regeneron. No two myasthenia gravis (MG) journeys look exactly alike. Symptoms can begin subtly, be misread or dismissed, and the path to diagnosis and long-term management can feel uncertain for people living with MG and caregivers alike. This variability is exactly why the voices of people with MG are so important. Regeneron, a leading biotechnology company that develops medicines for serious diseases, is taking a listen-first app






